India’s opportunity to build a preventive healthcare economy
India’s strength lies not just in technology availability, but in adoption behaviour
India’s strength lies not just in technology availability, but in adoption behaviour
MedGenome reaffirms its commitment to broaden access to quality and affordable genetic solutions for all
Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market
Subscribe To Our Newsletter & Stay Updated